These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25071009)

  • 1. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
    Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
    Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Luk IS; Shrestha R; Xue H; Wang Y; Zhang F; Lin D; Haegert A; Wu R; Dong X; Collins CC; Zoubeidi A; Gleave ME; Gout PW; Wang Y
    Clin Cancer Res; 2017 Mar; 23(6):1542-1551. PubMed ID: 27663589
    [No Abstract]   [Full Text] [Related]  

  • 3. BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells.
    Low CG; Luk IS; Lin D; Fazli L; Yang K; Xu Y; Gleave M; Gout PW; Wang Y
    PLoS One; 2013; 8(2):e55837. PubMed ID: 23409057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
    Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
    Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
    Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
    PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
    Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
    Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.
    Lamers F; Schild L; Koster J; Speleman F; Øra I; Westerhout EM; van Sluis P; Versteeg R; Caron HN; Molenaar JJ
    BMC Cancer; 2012 Jul; 12():285. PubMed ID: 22788920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
    Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
    BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo.
    Rodríguez L; Villalobos X; Dakhel S; Padilla L; Hervas R; Hernández JL; Ciudad CJ; Noé V
    Biochem Pharmacol; 2013 Dec; 86(11):1541-54. PubMed ID: 24070653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.
    McCann C; Crawford N; Majkut J; Holohan C; Armstrong CWD; Maxwell PJ; Ong CW; LaBonte MJ; McDade SS; Waugh DJ; Longley DB
    Cell Death Dis; 2018 Oct; 9(11):1081. PubMed ID: 30349042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.
    Sakao K; Desineni S; Hahm ER; Singh SV
    Prostate; 2012 Jul; 72(10):1104-16. PubMed ID: 22161756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
    Dai Y; Liu M; Tang W; DeSano J; Burstein E; Davis M; Pienta K; Lawrence T; Xu L
    Clin Cancer Res; 2008 Dec; 14(23):7701-10. PubMed ID: 19047096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
    Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
    BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.
    Gleave ME; Miyake H; Zellweger T; Chi K; July L; Nelson C; Rennie P
    Urology; 2001 Aug; 58(2 Suppl 1):39-49. PubMed ID: 11502446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.